XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Preferred Shares
Common Shares
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Distributions in Excess of Retained Earnings
Total Shareholders' Equity
Total Shareholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Non-Controlling Interests
Beginning balance (in shares) at Dec. 31, 2019   20,400,000 130,484,956              
Beginning balance at Dec. 31, 2019 $ 3,631,936 $ 204 $ 1,305 $ 4,069,410   $ (24,715) $ (424,996) $ 3,621,208   $ 10,728
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of shares, net of offering costs (119)     (119)       (119)    
Issuance of common shares for Board of Trustees compensation (in shares)     23,528              
Issuance of common shares for Board of Trustees compensation 637   $ 1 636       637    
Repurchase of common shares (in shares)     (47,507)              
Repurchase of common shares (1,255)   $ (1) (1,254)       (1,255)    
Share-based compensation (in shares)     103,083              
Share-based compensation 22,779   $ 1 12,162       12,163   10,616
Distributions on common shares/units (4,737)           (4,692) (4,692)   (45)
Distributions on preferred shares/units (32,556)           (32,556) (32,556)   0
Redemption of non-controlling interest LTIP units (in shares)     109,240              
Redemption of non-controlling interest LTIP units 0   $ 1 13,445       13,446   (13,446)
Equity component of convertible senior notes 113,890     113,890       113,890    
Purchases of capped calls in connection with convertible senior notes (38,300)     (38,300)       (38,300)    
Other comprehensive income (loss):                    
Change in fair value of derivative instruments (63,861)         (63,861)   (63,861)    
Amounts reclassified from other comprehensive income 28,505         28,505   28,505    
Net income (loss) (392,593)           (391,729) (391,729)   (864)
Ending balance (in shares) at Dec. 31, 2020   20,400,000 130,673,300              
Ending balance at Dec. 31, 2020 3,264,326 $ 204 $ 1,307 4,169,870 $ (113,099) (60,071) (853,973) 3,257,337 $ (113,099) 6,989
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Redemption of preferred shares (in shares)   (10,000,000)                
Redemption of preferred shares (250,000) $ (100)   (241,845)     (8,055) (250,000)    
Issuance of shares, net of offering costs (in shares)   19,200,000                
Issuance of shares, net of offering costs 464,054 $ 192   463,862       464,054    
Issuance of common shares for Board of Trustees compensation (in shares)     27,711              
Issuance of common shares for Board of Trustees compensation 516   $ 1 515       516    
Repurchase of common shares (in shares)     (38,310)              
Repurchase of common shares (720)   $ (1) (719)       (720)    
Share-based compensation (in shares)     151,049              
Share-based compensation 12,879   $ 1 10,433       10,434   2,445
Distributions on common shares/units (5,098)           (5,032) (5,032)   (66)
Distributions on preferred shares/units (42,105)           (42,105) (42,105)    
Purchases of capped calls in connection with convertible senior notes (20,975)     (20,975)       (20,975)    
Other adjustment 0         393   393   (393)
Other comprehensive income (loss):                    
Change in fair value of derivative instruments 15,289         15,026   15,026   263
Amounts reclassified from other comprehensive income 25,210         25,210   25,210    
Net income (loss) (186,372)           (184,858) (184,858)   (1,514)
Ending balance (in shares) at Dec. 31, 2021   29,600,000 130,813,750              
Ending balance at Dec. 31, 2021 3,163,905 $ 296 $ 1,308 4,268,042   (19,442) (1,094,023) 3,156,181   7,724
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Redemption of preferred shares (in shares)   (1,000,000)                
Redemption of preferred shares (16,000) $ (10)   (24,176)     8,186 (16,000)    
Issuance of shares, net of offering costs (123)     (123)       (123)    
Issuance of operating partnership units 78,000                 78,000
Issuance of common shares for Board of Trustees compensation (in shares)     33,866              
Issuance of common shares for Board of Trustees compensation 738   $ 1 737       738    
Repurchase of common shares (in shares)     (4,609,626)              
Repurchase of common shares (70,724)   $ (47) (70,677)       (70,724)    
Share-based compensation (in shares)     107,303              
Share-based compensation 11,350   $ 1 8,556       8,557   2,793
Distributions on common shares/units (5,104)           (5,035) (5,035)   (69)
Distributions on preferred shares/units (48,049)           (45,074) (45,074)   (2,975)
Other comprehensive income (loss):                    
Change in fair value of derivative instruments 55,479         55,114   55,114   365
Amounts reclassified from other comprehensive income 52         52   52    
Net income (loss) (84,981)           (87,171) (87,171)   2,190
Ending balance (in shares) at Dec. 31, 2022   28,600,000 126,345,293              
Ending balance at Dec. 31, 2022 $ 3,084,543 $ 286 $ 1,263 $ 4,182,359   $ 35,724 $ (1,223,117) $ 2,996,515   $ 88,028